Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency Presenting as Hyperammonemia and Encephalopathy: Case Series.

IF 0.9 Q4 CLINICAL NEUROLOGY
Cristina Viguera Altolaguirre, Andrew B Stergachis, David A Sweetser, Nina B Gold
{"title":"Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency Presenting as Hyperammonemia and Encephalopathy: Case Series.","authors":"Cristina Viguera Altolaguirre, Andrew B Stergachis, David A Sweetser, Nina B Gold","doi":"10.1177/19418744251324959","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited metabolic disorder (IMD) that affects the electron transfer chain and fatty acid oxidation. The late-onset form of MADD has a heterogenous clinical presentation that typically results in episodic lethargy, hypoglycemia, acidosis, and rhabdomyolysis during metabolic decompensations. <b>Purpose:</b> In this case report series we describe three cases of late-onset MADD presenting with hyperammonemia and encephalopathy, a less frequent but severe complication. <b>Methods:</b> the medical records of three patients with MADD and hyperammonemia were retrospectively analyzed for details surrounding their presentation and workup. <b>Results:</b> One patient had hyperammonemia to 445 μmol/L, obtundation, and seizures, requiring venovenous hemodialysis. Two patients had abnormal brain imaging findings. Two of the cases were initially diagnosed as hepatic encephalopathy, but treatment for this did not reverse the hyperammonemia. Workup for IMDs revealed biochemical profiles consistent with MADD, with non-diagnostic genetic testing. MADD-directed therapy led to a reversal of hyperammonemia and return to neurologic baseline of all patients. <b>Conclusion:</b> This series highlights hyperammonemia as a presentation of late-onset MADD, a potentially lethal but treatable disorder.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":" ","pages":"19418744251324959"},"PeriodicalIF":0.9000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881097/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurohospitalist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19418744251324959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited metabolic disorder (IMD) that affects the electron transfer chain and fatty acid oxidation. The late-onset form of MADD has a heterogenous clinical presentation that typically results in episodic lethargy, hypoglycemia, acidosis, and rhabdomyolysis during metabolic decompensations. Purpose: In this case report series we describe three cases of late-onset MADD presenting with hyperammonemia and encephalopathy, a less frequent but severe complication. Methods: the medical records of three patients with MADD and hyperammonemia were retrospectively analyzed for details surrounding their presentation and workup. Results: One patient had hyperammonemia to 445 μmol/L, obtundation, and seizures, requiring venovenous hemodialysis. Two patients had abnormal brain imaging findings. Two of the cases were initially diagnosed as hepatic encephalopathy, but treatment for this did not reverse the hyperammonemia. Workup for IMDs revealed biochemical profiles consistent with MADD, with non-diagnostic genetic testing. MADD-directed therapy led to a reversal of hyperammonemia and return to neurologic baseline of all patients. Conclusion: This series highlights hyperammonemia as a presentation of late-onset MADD, a potentially lethal but treatable disorder.

迟发性多发性酰基辅酶a脱氢酶缺乏表现为高氨血症和脑病:病例系列。
背景:多酰基辅酶a脱氢酶缺乏症(Multiple酰基辅酶a dehydrogenase deficiency, MADD)是一种影响电子传递链和脂肪酸氧化的遗传性代谢障碍(IMD)。迟发性MADD具有不同的临床表现,通常在代谢失代偿期间导致间歇性嗜睡、低血糖、酸中毒和横纹肌溶解。目的:在本病例报告系列中,我们描述了三例迟发性MADD,表现为高氨血症和脑病,这是一种不常见但严重的并发症。方法:回顾性分析3例MADD合并高氨血症患者的临床表现及随访资料。结果:1例患者高氨血症达445 μmol/L,伴有昏厥和癫痫发作,需要静脉静脉血液透析。2例患者有异常的脑成像结果。其中两例最初被诊断为肝性脑病,但治疗并没有逆转高氨血症。通过非诊断性基因检测,imd的生化特征与MADD一致。mad定向治疗导致所有患者的高氨血症逆转并恢复到神经系统基线。结论:这个系列强调高氨血症是迟发性MADD的一种表现,这是一种潜在致命但可治疗的疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurohospitalist
Neurohospitalist CLINICAL NEUROLOGY-
CiteScore
1.60
自引率
0.00%
发文量
108
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信